MedTrace Logo

Clinical Study on Prodovite® VMP35 Supplement on Athletic Performance

NCT04121481 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2021-05-07

No results posted yet for this study

Summary

This pilot investigation will conduct a randomized placebo-controlled, double-blind study in 150 volunteers (age: 18-74 years) over a period of 90 consecutive days. A statistician will be involved in this project. Body weight, body mass index (BMI), waist circumference, blood chemistry, blood pressure and heart rate, body and hand grip strength, speed and endurance studies including open circuit spirometry-based assessment of pulmonary function will be assessed. Other parameters to be evaluated include oxygen consumption, CO2 production and metabolic parameters, VO2 max, respiratory exchange ratio (RER), anaerobic threshold, ventilatory equivalents for oxygen (VE/V02) and exhaled carbon dioxide (VE/VC02)2,3. Subjects will participate in completed maximal graded exercise tests (GXT) on a treadmill or in set distance open-field sprints using open-circuit spirometry. Lower and Upper Body Strength will be evaluated. E-Diary will be provided to all participants. Survey Monkey program will be provided to all subjects and regularly updated by all study participants daily and endorsed by the co-Principal Investigator.

Conditions

  • Athletic Performance

Interventions

DIETARY_SUPPLEMENT

Clinical Investigation on Enhanced Sports Nutrition and Performance Activities by Prodovite VMP35 Supplement

Assess the Sports Nutrition efficacy of Prodovite VMP35 against the Placebo sample

DIETARY_SUPPLEMENT

Broad Spectrum Safety

Benefits in Sports Nutrition

Sponsors & Collaborators

  • Victory Nutrition International, Inc.

    lead INDUSTRY

Principal Investigators

  • BRUCE S MORRISON, DO · SPORTS NUTRITION & FAMILY MEDICINE

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-15
Primary Completion
2022-01-31
Completion
2022-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04121481 on ClinicalTrials.gov